MetaCap

Insulet (PODD) vs Solventum (SOLV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Solventum (SOLV) has outperformed Insulet (PODD) over the past year, gaining 1.9% versus a loss of 59.8%. Solventum is the larger company by market cap ($14.36 billion vs $9.24 billion), about 1.6 times the size, while Insulet is growing revenue faster (+30.7% vs +0.9%). On valuation, Solventum trades at a lower forward P/E (11.2x vs 16.8x for Insulet).

Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 9.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PODD-59.79%SOLV+1.93%
+15%-25%-64%
Nov 21, 20251 yearNov 20, 2026
PODD-22.30%SOLV+21.50%
+110%+37%-36%
Mar 25, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PODD versus SOLV key metrics
MetricPODDSOLV
Share price$133.17$84.50
Market cap$9.24B$14.36B
1-day change-2.96%-1.52%
YTD return-53.15%+6.64%
1-year return-59.79%+1.93%
5-year return-54.92%—
P/E ratio (TTM)21.7694.94
Forward P/E16.8311.20
EPS (TTM)$6.12$0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.71B$8.32B
Revenue growth (YoY)+30.73%+0.86%
Net income (latest FY)$247.10M$1.56B
Gross margin71.63%53.47%
Operating margin17.50%26.20%
Net margin9.12%18.69%
52-week high$342.13$94.16
52-week low$126.40$62.38
Distance from 52-week high-61.08%-10.26%
Analyst consensusbuybuy
Avg. price target upside+33.60%+16.43%
Average volume1.61M1.03M
Shares outstanding69.37M169.96M
Employees5,40020,584
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SOLV has outperformed PODD by 61.7 percentage points over the past year.
  • Solventum trades at a higher earnings multiple (94.9x vs 21.8x trailing P/E).
  • Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 9.1 cents for Insulet.
  • Insulet grew revenue faster in its latest fiscal year (+30.73% vs +0.86%).

About Insulet

PODD stock →

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System.

Health Care · Medical/Dental Instruments · 5,400 employees

About Solventum

SOLV stock →

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.

Health Care · Medical/Dental Instruments · 20,584 employees

PODD vs SOLV FAQ

Which is bigger, Insulet or Solventum?

Solventum (SOLV) is larger, with a market capitalization of $14.36B compared with $9.24B for Insulet (PODD).

Which stock has performed better over the past year, PODD or SOLV?

SOLV returned +1.93% over the past 12 months, compared with -59.79% for PODD (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, PODD or SOLV?

PODD has the lower trailing P/E at 21.8, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Insulet and Solventum in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons